Abstract

The physiological impact of the aberrant oxidation products on genomic DNA were demonstrated by embryonic lethality or the cancer susceptibility and/or neurological symptoms of animal impaired in the base excision repair (BER); the major pathway to maintain genomic integrity against non-bulky DNA oxidation. However, growing evidence suggests that other DNA repair pathways or factors that are not primarily associated with the classical BER pathway are also actively involved in the mitigation of oxidative assaults on the genomic DNA, according to the corresponding types of DNA oxidation. Among others, factors dedicated to lesion recognition in the nucleotide excision repair (NER) pathway have been shown to play eminent roles in the process of lesion recognition and stimulation of the enzyme activity of some sets of BER factors. Besides, substantial bulky DNA oxidation can be preferentially removed by a canonical NER mechanism; therefore, loss of function in the NER pathway shares common features arising from BER defects, including cancer predisposition and neurological disorders, although NER defects generally are nonlethal. Here we discuss recent achievements for delineating newly arising roles of NER lesion recognition factors to facilitate the BER process, and cooperative works of BER and NER pathways in response to the genotoxic oxidative stress.

Highlights

  • The integrity of the genome is endlessly threatened by reactive oxygen species (ROS) formed in living cells as metabolic byproducts

  • The results indicate that after cerebral ischemia, the accumulation of brain oxidative DNA base lesions was significantly greater in OGG1-deficient mice, and was associated with greater brain damage and poorer behavioral outcomes, revealing an important role for OGG1 in brain base excision repair (BER) capacity, which contributes to neuronal survival after experimental stroke [15]

  • nucleotide excision repair (NER) is famous for the unique repair pathway in humans to remove photolesions produced by UV radiation that mainly forms cyclobutane pyrimidine dimer (CPD), a non-bulky lesion and pyrimidine-(6,4)-pyrimidone product (6-4PP), a bulky lesion

Read more

Summary

Introduction

The integrity of the genome is endlessly threatened by reactive oxygen species (ROS) formed in living cells as metabolic byproducts. It has been estimated that as many as ten thousand oxidation reactions harm DNA per each human cell per day [1], which eventually produces a plethora of non-bulky (purine/pyrimidine base oxidations) and bulky (crosslinks, strand breaks, and cyclic bases) DNA lesions. These lesions, if not timely repaired, can interfere with essential DNA metabolisms, including transcription, recombination, and replication, which can give rise to unfavorable outcomes like cellular senescence and mutagenesis. The addition of more than one nucleotide (up to 13) constitutes long-patch BER and requires the assistance of flap endonuclease 1 (FEN1) to remove the displaced 5 -flap structure (Figure 1)

General Features of BER Defect
Nucleotide Excision Repair
General Features of NER Defect
Facilitated BER Kinetics by the NER Lesion Recognition Factors
UV-DDB
Bulky Lesions
Non-Bulky Lesions
Findings
Concluding Remarks
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call